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Abstract
Background: In diabetes chronic hyperinsulinemia contributes to the instability of the atherosclerotic plaque and stimulates
cellular proliferation through the activation of the MAP kinases, which in turn regulate cellular proliferation. However, it is
not known whether insulin itself could increase the transcription of specific genes for cellular proliferation in the
endothelium. Hence, the characterization of transcriptional modifications in endothelium is an important step for a better
understanding of the mechanism of insulin action and the relationship between endothelial cell dysfunction and insulin
resistance.
Methodology and principal findings: The transcriptional response of endothelial cells in the 440 minutes following insulin
stimulation was monitored using microarrays and compared to a control condition. About 1700 genes were selected as
differentially expressed based on their treated minus control profile, thus allowing the detection of even small but
systematic changes in gene expression. Genes were clustered in 7 groups according to their time expression profile and
classified into 15 functional categories that can support the biological effects of insulin, based on Gene Ontology
enrichment analysis. In terms of endothelial function, the most prominent processes affected were NADH dehydrogenase
activity, N-terminal myristoylation domain binding, nitric-oxide synthase regulator activity and growth factor binding.
Pathway-based enrichment analysis revealed ‘‘Electron Transport Chain’’ significantly enriched. Results were validated on
genes belonging to ‘‘Electron Transport Chain’’ pathway, using quantitative RT-PCR.
Conclusions: As far as we know, this is the first systematic study in the literature monitoring transcriptional response to
insulin in endothelial cells, in a time series microarray experiment. Since chronic hyperinsulinemia contributes to the
instability of the atherosclerotic plaque and stimulates cellular proliferation, some of the genes identified in the present
work are potential novel candidates in diabetes complications related to endothelial dysfunction.
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Introduction
Diabetic patients die because of the long term chronic
complications, namely cardiovascular macroangiopathy, nephrop-
athy, and neuropathy due to the harmful effects of prolonged
hyperglycemia in these tissues. From a pathophysiological
standpoint, insulin-resistance, a typical metabolic condition in
Type 2 diabetic patients initially induces a compensatory
hyperinsulinemia, which carries on a proliferative effect among
the cellular component of the vascular wall. Chronically elevated
insulin concentrations may promote vascular lesion formation; in
patients with insulin resistance, such as those with metabolic
syndrome, there is an increased risk of cardiovascular disease
[1,2]. Further, hyperinsulinemia contributes to for the instability of
the atherosclerotic plaque: it increases the active forms of
matrixmetalloproteinases (MMP)-2, MMP-9, and membrane type
1-MMP and the gelatinolytic activity of MMP-2 [3]. Furthermore,
insulin may exerts a vasodilator action mediated by phosphatidy-
linositol 3-kinase (PI3K)-dependent signaling pathways that
stimulates the production of nitric oxide from vascular endothe-
lium. In states of insulin resistance, shared glucotoxicity,
lipotoxicity, and inflammation selectively impair PI3K-dependent
insulin signaling pathways: this contributes to the reciprocal
relationships between insulin resistance and endothelial dysfunc-
tion [4]. In addition, insulin exerts a plethora of other effects such
as the suppression of nuclear factor (NF)-kB, intracellular adhesion
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molecule (ICAM)-1, monocyte chemoattractive protein (MCP)-1,
and of NADPH oxidase [5].
Nonetheless, it is unknown whether insulin itself could
increase the transcription of specific genes in the endothelial
cells. This is biologically relevant since endothelium itself has a
powerful regulatory effect on the underlying vascular smooth
muscular cells [6,7]. Hence, the characterization of the global
pattern of transcriptional modifications in the endothelium is
important for better understanding the mechanism of action of
insulin. The development of microarray technology represents a
powerful tool for characterizing such large-scale changes in
transcript levels. For example, this methodology was applied to
investigate the effects of intensive insulin treatment for 10 days
on the mRNA profile in skeletal muscle of type 2 diabetic
patients [8]. With a similar methodology, it has been shown that
insulin directly modulates the mRNA levels of about 800 genes
induced by 3 hours of euglycemic hyperinsulinemic clamp in the
vastus lateralis muscle of healthy lean subjects [9]. More
recently, it has been shown that insulin is able to regulate
different processes within the placenta at different gestational
stages, using a global microarray analysis of primary trophoblasts
[10]. In pre/post stimulus studies in which the transcriptional
response is monitored at one specific time instant after a
prolonged insulin exposure, genes showing a transient response
followed by a return to the pre-stimulus expression or a
systematic, but small in magnitude, change in the expression,
are likely to be missed [11]. On the opposite, monitoring the
dynamic response using more than one time samples after the
stimulus allows detecting these genes as differentially expressed
and provides a description of the transcriptional expression
patterns of the response. Transient behavior might be charac-
teristic, and, if common to a number of genes associated to the
same functional group, might give insight into the function
performed by the gene circuitry. The aim of the present work is
to exploit the potential of a dynamic study to investigate the
dynamic transcriptional response of endothelial cells following
insulin stimulation. As far as we know, this has not been
previously addressed in the literature for endothelial cells
stimulated with insulin.
To distinguish between insulin effect and other processes that
take place in the cell simultaneously, but are not induced or
inhibited by insulin, treated cells were compared with control cells.
Experiments were carried out on human umbilical vein endothe-
lial cells (HUVECs). As far as we know, this is the first systematic
study in the literature monitoring transcriptional response to
insulin in endothelial cells, in a time series microarray experiment.
Materials and Methods
Cell Cultures
Human umbilical vein endothelial cells (HUVECs) were
obtained from Promocell (PromoCell, Heidelberg, Germany) from
a single donor. These cells were certified to be free from
mycoplasma contamination and tested negative for HIV, HBV
and HCV virus infections or contamination by PCR results. Cells
were cultured in Endothelial Cell Growth Medium (PromoCell)
which is a modified MCDB 131 medium, supplemented with 10%
fetal bovine serum (FBS) (Sigma Aldrich, Saint Louis, USA),
0.02% Supplement Mix/ Endothelial Cell Growth Medium
(PromoCell), 100 U/ml penicillin and 100 mg/ml streptomycin
(Sigma Aldrich). All cells were maintained in a humidified 5%
CO2 incubator at 37uC, and the medium was replaced every 2
days until confluence. All the experiments reported in this paper
were carried out on cells between 4th and 5th passage.
Experimental design
HUVECs were seeded onto six well plates at a density of 26105
per well and cultured as described above. At the second day, cells
were incubated overnight with 1% FBS medium, without growth
factors. The day of the experiment, 1 ml of quiescent medium, in
absence or presence of 1 mU/ml (7 nM) insulin (Calbiochem-
Inalco Spa), was added to each well. Cells of three wells were
pooled and used for each time point. Samples were collected at
times 0, 40, 100, 200, 340, 440 min. Time 0 was cultured and
harvested in duplicate so to have a complete experimental
replicate of time 0 sample. HUVECs were harvested at the
designated time points, and RNA was extracted and quantified for
Microarray analysis (Affymetrix measurement) The medium with
insulin was collected and stored at 220uC for the insulin detection
(Insulin Myria, Technogenetics), while the medium without insulin
was discharged. In order to validate the Affymetrix measurements,
a quantitative real-time polymerase chain reaction was performed.
The experimental design described above was repeated. Samples
were collected at time 0, 30, 60, 120, 180, 240, 300, 360, 420,
480 min. All the experiments were carried out in duplicate.
RNA extraction
Cells were washed with phosphate buffered saline (PBS). Total
RNA was extracted using a commercially available kit (TRIzol
Reagent, Invitrogen) and stored at 280uC. The samples were
further purified using RNeasy mini kit (Qiagen, Milan, Italy)
following manufacturer’s recommendations. The integrity of RNA
was systematically checked by use of the lab-on-chip technology in
an Agilent Bioanalyzer 2100 with the RNA6000 Nano Assay
(Agilent Technologies, Palo Alto, CA). Furthermore the purity was
determined by spectrophotometric readings at 260/280/230 nm.
Affymetrix Measurements
Total RNAs were purified using an RNeasy Protect Mini Kit
from Qiagen. The quality and quantity of total RNA was
measured using the Agilent test on a Bioanalyzer (Agilent
Technologies, Palo Alto, CA). Gene transcript profiles in both
control and treated cultures were studied by high-density
oligonucleotide microarrays Human Genome U133 Plus 2.0
GeneChip (Affymetrix, Santa Clara, CA). Sample labeling,
hybridization of test array, and hybridization of full-size arrays
were performed using protocols described in the Affymetrix
GeneChip expression analysis technical manual.
Affymetrix Data Analysis
Image quantification was performed using GeneChip (Affyme-
trix, SantaClara, CA) scanner and software. Preprocessing steps
such as background subtraction, probe cell normalization and
expression level calculations, were performed using quantile
normalization and Robust Microarray Analysis (RMA) software
[12]. High-level data analysis was carried out in a pipeline as
shown in Figure 1.
Selection. Differentially expressed genes were selected using
the method described in [11] that calculates the area of the region
bounded by the treated-minus-control expression profile and
assigns a p-value to each gene by evaluating the significance of this
area against the null hypothesis. The two replicates available at
time zero were used to derive the experimental error distribution
at different intensity expression values and, consequently, the null
hypothesis distribution of the area bounded by the treated-minus-
control expression profile. As already shown in [11], the method,
implemented for data poor conditions, is quite robust to random
oscillation, and help diminishing both false positive and false
HUVEC RNA Response to Insulin
PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e14390
negative rates. In order to account for multiple testing, the
significance level was corrected according to a false discovery rate
(FDR), i.e. the number of false positives divided by the number of
selected genes, of 0.05.
GO and pathway enrichment. Genes were annotated
according to molecular functions of Gene Ontology (GO)
database [13], using NetAffx database (http://www.affymetrix.
com/analysis/index.affx). Enrichment analysis was performed
based on a strategy similar to the ‘‘elim’’ method described in
[14]. GO terms (related to different molecular functions) were
grouped into levels according to the percentages of selected genes:
namely, level 1 corresponds to GO terms with at least 98%–100%
of their annotations selected, level 2 to the range 96%–98%, etc.
Starting from level 1, the algorithm visited each level and for each
GO term performed Fisher’s Exact Test that assigns a p-value
representing the probability that the observed number of selected
genes annotated to the GO term could have resulted from random
sampling. If in the visited level a GO term has a p-value below a
significance level a, then the corresponding genes were removed
from the annotation of GO terms having lower percentages, in
order to penalize their p-value. In this way, the number of
enriched GO terms was kept low, still maintaining a high
significance level. Since this test was applied to a large number
of GO terms, the significance level a for the calculated p-values
was empirically set to 0.0025.
To identify the most enriched pathways, selected genes were
also annotated to WikiPathways (http://www.wikipathways.org)
using NetAffx database. Enrichment analysis of pathways was
performed using Fisher’s Exact Test.
GO grouping. To obtain a more synthetic annotation, the
enriched nodes directly connected by a path in the GO graph were
grouped together in the same functional cluster. Each GO group,
thus characterized by an isolated sub-graph of siblings or ancestors
terms, was labeled with the most general of these terms.
Clustering. To identify the main temporal expression
patterns in response to insulin stimulus, treated-minus-control
expression profiles of selected genes were clustered using K means
clustering based on Pearson correlation. The number K of clusters
was set to 7.
Cluster-specific GO group enrichment. For each cluster
and for each GO group defined above, GO enrichment based on
Fisher’s Exact Test was calculated separately, so that the resulting
p-value represents the probability that the observed numbers of
selected genes belonging to the cluster and annotated with the GO
group have resulted from random sampling. GO groups with p-
value,0.05 were considered as significantly enriched for the
cluster.
Validation via qRT-PCR
Affymetrix data validation was performed using qRT-PCR, by
monitoring a subset of 32 genes belonging to the electron transport
chain pathway, of which 21 selected and 11 not selected as
differentially expressed using Affymetrix data (see results section).
HUVECs for this experiment were obtained from a second donor
(Promocell). Real-Time PCR Analysis of Gene Expression. cDNAs
were reverse transcribed from total RNA samples (100 ng) using
the High Capacity cDNA Reverse Transcription Kit (Life-
Technologies-Applied Biosystems, Foster City, CA, USA). Taq-
Man PCRs were carried out onto custom TaqMan low-density
arrays by means of the ABI PRISM 7900 HT Sequence Detection
Systems (all from Life Technologies-AppliedBiosystems). Statistical
analyses were obtained using the 2-Delta-delta-Cycle Threshold
values (Delta-delta-CTs) method, with the Threshold determined
automatically by means of SDS software (Life Technologies-
Applied Biosystems). To normalize data, CT was calculated for
each detector by using the median of CTs in all samples as
calibrator. The relative quantity (RQ) of each mRNA was
calculated as 22DDCT. Differentially expressed genes were selected
by applying the method described in [11], using a significance
level alpha equal to 0.05 on the detected false discovery rate
p-values.
The overlap in the lists of differentially expressed genes selected
by Affymetrix and qRT-PCR was quantified by means of a
contingency table, while the dynamic patterns of expression were
compared in terms of up and down regulation.
Results
Affymetrix Data Analysis
Selection. 2326 probe-sets, associated to 1715 genes, were
selected as differentially expressed in the cells exposed to insulin.
GO and pathway enrichment. Functional annotations of
selected genes indicate that 26 molecular functions are significantly
affected by insulin (Table 1). In terms of endothelial function, the
most prominent processes affected were oxidoreductase activity,
acting on NADH or NADPH, quinone or similar compound as
acceptor, NADH dehydrogenase activity, NADH dehydrogenase
(ubiquinone) activity, NADH dehydrogenase (quinone) activity,
cell adhesion molecule binding, protein transporter activity, N-
terminal myristoylation domain binding, nitric-oxide synthase
regulator activity, and growth factor binding.
Enrichment analysis revealed one significantly enriched path-
ways: ‘‘Electron Transport Chain’’, containing 28 of the selected
genes on a total of 118 annotated genes.
Figure 1. Pre-processed Affymetrix data analysis pipeline. A
selection method was applied to identify differentially expressed genes.
Selected genes were clustered according to their time expression
profile; significantly associated pathways and GO terms were identified
through enrichment analysis. The enriched GO terms were grouped into
different functional categories. For each cluster and for each GO
category, GO enrichment based on Fisher’s Exact Test was calculated.
doi:10.1371/journal.pone.0014390.g001
HUVEC RNA Response to Insulin
PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e14390
GO grouping. The GO sub-graph containing all the paths
from the 26 enriched GO terms to the root is depicted in Figure 2,
where enriched GO terms are grouped together into 15 main GO
groups, according to the rules explained in Methods; namely,
Protein binding, Actin binding, N-terminal myristoylation domain
binding, Nitric-oxide synthase regulator activity, RNA binding,
Structure-specific DNA binding, Translation initiation factor
activity, Transcription corepressor activity, NADH dehydrogenase
activity, 1-phosphatidylinositol-3-kinase activity, RNA polymerase
subunit kinase activity, Protein geranylgeranyltransferase activity,
Cis-trans isomerase activity, Hydrolase activity, Protein transporter
activity. Ten out of fifteen groups correspond to isolated nodes in
the GO database.
Clustering and cluster-specific GO group enrichment.
Seven main temporal patterns in response to insulin stimulus were
identified for treated-minus-control expression profiles as shown in
Figure 3 (left panels), together with the number of genes correlated
to each pattern. For each cluster the specific enrichments in the 15
different GO groups was expressed as (12p-value), as shown in
Figure 3 (right panels), so that a value close to 1 indicates an
elevated significance level.
Cluster 1, characterized by a peak of the expression level at time
200 min, is significantly associated with GO groups B (actin
binding) and C (N-terminal myristoylation domain binding), in
which three genes coding for calmodulin are annotated.
Cluster 2 shows initial down-regulation followed by a plateau;
even if genes belonging to GO groups G (translation initiation
factor activity) and M (cis-trans isomerase activity) are highly
represented in this cluster, it does not reach significance for any
GO group.
Cluster 3 shows an initial decrease in the expression level and a
return to a pre-stimulus expression, significant in GO groups E
(RNA binding) and I (NADH dehydrogenase activity).
Cluster 4 shows a transient rise of expression level, followed by a
decrease, significant in GO group D (nitric oxide synthase
regulator activity).
Cluster 5 shows up-regulation at time 100 min, followed by a
plateau; even if genes belonging to GO group A (protein binding),
B (actin binding) and F (structure-specific DNA binding) are highly
represented in this cluster, it does not reach significance for any
GO group.
Cluster 6 shows down regulation of expression at time 100 min
and 340 min, significantly associated with GO group M (cis-trans
isomerase activity).
Cluster 7 shows consistent down-regulation, significant in GO
group J (1-phosphatidylinositol-3-kinase activity).
Table 1. Enriched Gene Ontology molecular functions.
GOID TERM Annotated Selected p-value
GO:0005515 protein binding 8020 913 1.03E-13
GO:0003723 RNA binding 835 131 5.40E-10
GO:0016462 pyrophosphatase activity 785 102 7.81E-07
GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides 788 102 9.51E-07
GO:0016817 hydrolase activity, acting on acid anhydrides 796 102 1.59E-06
GO:0016655 oxidoreductase activity, acting on NADH or NADPH, quinone or similar
compound as acceptor
57 18 1.62E-06
GO:0003954 NADH dehydrogenase activity 52 16 8.87E-06
GO:0008137 NADH dehydrogenase (ubiquinone) activity 52 16 8.87E-06
GO:0050136 NADH dehydrogenase (quinone) activity 52 16 8.87E-06
GO:0017111 nucleoside-triphosphatase activity 755 95 8.96E-06
GO:0003779 actin binding 341 60 5.87E-05
GO:0051015 actin filament binding 44 14 1.99E-04
GO:0050839 cell adhesion molecule binding 25 9 2.30E-04
GO:0008565 protein transporter activity 97 20 2.94E-04
GO:0008353 RNA polymerase subunit kinase activity 5 4 3.36E-04
GO:0003755 peptidyl-prolyl cis-trans isomerase activity 57 14 3.89E-04
GO:0016859 cis-trans isomerase activity 58 14 4.72E-04
GO:0003743 translation initiation factor activity 74 16 6.66E-04
GO:0031997 N-terminal myristoylation domain binding 3 3 7.92E-04
GO:0004661 protein geranylgeranyltransferase activity 6 4 9.25E-04
GO:0030235 nitric-oxide synthase regulator activity 6 4 9.25E-04
GO:0043566 structure-specific DNA binding 146 25 1.06E-03
GO:0003714 transcription corepressor activity 137 23 1.08E-03
GO:0016303 1-phosphatidylinositol-3-kinase activity 11 5 1.86E-03
GO:0019838 growth factor binding 98 18 1.95E-03
GO:0051082 unfolded protein binding 120 24 2.46E-03
For each enriched GO term the GOID and the corresponding name are shown, with the number of genes annotated in the GO database (Annotated), the number of
genes selected as differentially expressed annotated in the GO database (Selected) and the p-value evaluated as described in Methods.
doi:10.1371/journal.pone.0014390.t001
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Table S1 contains an Excel file with 15 worksheets showing the
selected genes belonging to each GO group. In the file, for each
group, the list of genes, their symbols, titles, chromosome
locations, expression clusters and FDR p-values obtained by
selection method are shown. To give a more complete and easy to
access information about the direction and magnitude of change,
for each time point significant changes in gene expression were
identified based on a model of the error obtained using the two
available replicates at time 0 [15]. Since the purpose here is to
indicate the sign and the magnitude of the change and not to select
genes, we fixed the threshold so to minimize the sum of false
positive and false negative rates as explained in [15]. The direction
and the magnitude of the changes are indicated only when they
result significant. Complete time-series expression data of each
gene are available in GEO database (GSE21989).
Validation via qRT-PCR
To validate Affymetrix measurements, 32 genes related to
‘‘Electron Transport Chain’’ pathway were monitored using qRT-
PCR, as explained in Methods. As shown in Table 2, 21 of these
genes were selected as differentially expressed from Affymetrix
measurements, while 28 were selected from qRT-PCR measure-
ments. The overall overlap (Figure 4) is 72%, indicating a good
agreement between the two techniques. In particular, 20 of the 21
genes selected as differentially expressed by using Affymetrix chip
are also selected by qRT-PCR, showing an overlap of 95%.
However, 8 genes selected using qRT-PCR are not selected using
Affymetrix chips, probably due to the better precision of qRT-
PCR technology to measure low RNA concentration with respect
to Affymetrix chips.
There is also a good agreement in the time expression profiles
of the ‘‘Electron Transport Chain’’ obtained with the two
techniques. In fact, the expression profiles of the 21 Affymetrix
selected genes are all associated to clusters 2 and 3 (apart from
gene NARG1, associated to cluster 7), indicating a prevalent
down-regulation of genes belonging to ‘‘Electron Transport
Chain’’ pathway. The 28 time series of qRT-PCR selected genes
share a similar temporal pattern, characterized by an early rise of
expression level at time 30 min, followed by an increasing down-
regulation (Figure 5). Since the early response was not monitored
by Affymetrix, we can conclude that the two techniques reveal
similar response to insulin for genes related to ‘‘Electron
Transport Chain’’.
Discussion
The objective of this study was to utilize DNA microarray
technology to assess the transcriptional response to insulin in
endothelial cells, in a time series microarray experiment. These
experiments were performed by exposing endothelial cells derived
from human umbilical veins to pharmacologic insulin concentra-
tions.
To identify significant transcriptional temporal patterns in
endothelial cells treated with insulin and to characterize them from
a functional point of view, an ad hoc analysis pipeline was applied
to experimental data. In particular: 1) Differentially expressed
Figure 2. GO graph of enriched molecular function terms. The paths of GO enriched terms are displayed; nodes directly connected by a path
in the GO graph were grouped together into 15 GO main annotation groups (denoted by capital letters).
doi:10.1371/journal.pone.0014390.g002
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genes, selected by using a method tailored for gene expression time
series in data-poor conditions, were annotated according to Gene
Ontology molecular functions; 2) The enriched GO terms were
grouped together according to their position in the GO graph in
order to obtain a more synthetic annotation and these groups were
used to annotate the main temporal expression patterns identified
by cluster analysis. This approach selects genes based on their
dynamic gene expression profiles, thus detecting even small but
systematic changes in gene expression. Then, by integrating cluster
analysis and functional annotations, it gives a limited number of
non-redundant functional groups.
Application of the analysis pipeline to Affymetrix data
demonstrates the followings:
1. Endothelial genomic response is significantly affected by
elevated insulin concentrations;
2. These effects are characterized by remarkably different
temporal profiles.
Figure 3. Cluster-specific GO group enrichment. Left panels show temporal expression profiles (treated minus control) of genes belonging to
each cluster, identified by K-means algorithm; middle panels represent the corresponding average temporal patterns; right panels show significance
of the enrichment for each GO category (identified by capital letters) in each cluster, as 1 minus p-value. A star indicates significant GO groups (with
p-value , 0.05).
doi:10.1371/journal.pone.0014390.g003
Table 2. Genes monitored by qRT-PCR.
Gene Symbol Gene Name
Selected
qRT-PCR Selected Affy GOgroup Cluster
ATP5A1 ATP synthase, F1 complex, alpha subunit 1 Yes No A ---
ATP5C1 ATP synthase, F1 complex, gamma polypeptide 1 Yes Yes N 3
ATPIF1 ATP synthase, F0 complex, subunit B1 Yes No A ---
ATP5F1 ATP synthase, F0 complex, subunit B1 Yes Yes A,N 2
ATP5G1 ATP synthase, F0 complex, subunit C1 No No --- ---
ATP5I ATP synthase, F0 complex, subunit E Yes Yes N 2
ATP5L ATP synthase, F0 complex, subunit G No No A ---
ATP5O ATP synthase, F1 complex, O subunit Yes No --- ---
BTF3 basic transcription factor 3 Yes Yes A 2
CYCS cytochrome c, somatic Yes Yes A 2
COX17 cytochrome c oxidase assembly homolog Yes Yes --- 3
COX6B1 cytochrome c oxidase subunit Vib Yes Yes --- 3
COX5B cytochrome c oxidase subunit Vb Yes Yes --- 3
COX7B cytochrome c oxidase subunit VIIb Yes No --- ---
COX7C cytochrome c oxidase subunit VIIc Yes Yes --- 3
NARG1 NMDA receptor regulated 1 Yes Yes A 7
NDUFA2 NADH dehydrogenase, alpha, subunit 2 Yes Yes I 2
NDUFA3 NADH dehydrogenase, alpha, subunit 3 Yes Yes I 2
NDUFA6 NADH dehydrogenase, alpha, subunit 6 Yes Yes I 2
NDUFA7 NADH dehydrogenase, alpha, subunit 7 Yes Yes I 2
NDUFA12 NADH dehydrogenase, alpha, subunit 12 Yes Yes I 2
NDUFB2 NADH dehydrogenase, beta, subunit 2 Yes Yes I 2
NDUFB3 NADH dehydrogenase, beta, subunit 3 No Yes I 2
NDUFS1 NADH dehydrogenase, Fe-S protein 1 Yes Yes A,I 2
NDUFS4 NADH ubiquinone oxidoreductase IP subunit mRNA Yes Yes I 2
NDUFV2 NADH dehydrogenase flavoprotein 2 Yes No I ---
SDHA succinate dehydrogenase, subunit A Yes No --- ---
SDHB succinate dehydrogenase, subunit B Yes Yes A 2
SLC25A6 solute carrier family 25 Yes No A ---
UCP2 uncoupling protein 2 No No A ---
UQCRB ubiquinol-cytochrome c reductase binding protein Yes Yes --- 3
UQCRC2 ubiquinol-cytochrome c reductase core protein II Yes No A ---
For each of the 32 measured genes, the corresponding symbol and name are shown, with the information on selection results for qRT-PCR (Selected qRT-PCR) and for
Affymetrix (Selected Affy). The association with the GO groups and the clusters defined in Figure 3 are also shown.
doi:10.1371/journal.pone.0014390.t002
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Differently from previous works in the literature that monitor
gene expression in endothelial cells in static conditions before and
after insulin stimuli, we focus here on the dynamic response of
endothelial cells to insulin stimulation. This approach allowed us
to detect as differentially expressed also genes that respond to
insulin with a transient response followed by a return to the
baseline condition or with a small, even thought systematic, i.e.
sustained in time, change in gene expression. These genes would
not have been detected with a pre/post stimulus study of
transcriptional response in which only one specific time instant is
considered after insulin exposure,. For example, most of the genes
in cluster 3 and 4, enriched of genes belonging to RNA binding,
NADH dehydrogenase activity and nitric-oxide synthase regulator
activity GO groups (Figure 3), would have not been detected by a
pre/post stimulus study.
Insulin responsive genes were characterized in terms of dynamic
pattern and functional annotation. This is of importance due to
the specific contribution of insulin not only to glucose metabolism
but also to the vascular homeostasis. It is known that insulin
mediates the metabolic-hemodynamic coupling by increasing the
microvascular exchange surface perfused within skeletal muscle
[16]: this may be relevant in conditions of insulin resistance where,
at least in muscle, insulin not only is unable to induce a proper
vasodilatation but also the up regulation of genes such hexokinase
II, p85aPI3K, and SREBP-1c which are critical for intracellular
insulin signaling and glucose transporter recruitment [17]. Consoli
and colleagues [18] have also shown that, at endothelial levels,
genetic insulin resistance may be postulated, leading to a possible
imbalance of prothrombotic and fibrinolytic genes.
Notwithstanding that arterial and venous derived endothelial
cells differ from HUVECs for anatomical, functional, and
transcriptional identities, we select the latter in our experimental
setting [19,20] since they are commonly employed in experimental
protocols which investigate the effects of insulin on endothelial
functions [21] and on gene expression [16].
Our data show that insulin exposure is associated in HUVECs
with different patterns of differential expression. Cluster 1
(Figure 3) relates to N-terminal myristoylation domain binding a
molecular function which indicates the selective interaction with
the N-terminus of a protein; binding affinity is altered by
myristoylation. On this specific effect only few reports are
available. Interestingly, in an experimental model of diabetic
rodents, the N-myristoyltransferase in the liver is increased as
compared to control whereas in obese rodents is decreased. In the
endothelial cells this process may be of importance since it was
shown that the eNOS is post-translationally modified by
myristoylation of Gly2 [22,23] and it is important in the interplay
between phosphorylation and subcellular localization of eNOS
[24].
In cluster 4, we have shown a rise, albeit transitory, of the GO
group D which refers to nitric oxide synthase regular activity. As
expected, insulin exposure is able to increase NO production by
endothelial cells [25]. Nitric oxide synthase gene expression may
be regulated at multiple levels: epigenetic, transcriptional, and
posttranscriptional processes [26]. As shown by Kuboki and
colleagues in cultured bovine aortic endothelial cells, insulin can
regulate the expression of eNOS gene, mediated by the activation
of PI-3 kinase [27]. This observation has been further replicated
[28]. Very little information is available in the literature about the
temporal stimulation of nitric oxide gene activation at least in
arterial derived endothelial cells. Yet, at least endothelial nitric
oxide synthase protein may be characterized by a remarkable
temporal expression in rat femoral artery [29]. Our differential
expression pattern shows that the GO group ‘‘nitric oxide synthase
regulator activity’’ is temporally regulated by insulin stimulation.
This observation might be taken with caution since eNOS
expression itself is not changed. Furthermore, this temporal
expression is detected by incubating the endothelial cells at
Figure 4. Comparison between Affymetrix and qRT-PCR.
Contingency table that compares the lists of selected/not selected
genes belonging to Electron Transport Chain pathway for both
Affymetrix and qRT-PCR experiments. 21 of the 32 genes monitored
by qRT-PCR were selected as differentially expressed from Affymetrix
measurements, while 28 were selected from qRT-PCR measurements. In
particular, 20 of the 21 genes selected as differentially expressed by
using Affymetrix chips are also selected by qRT-PCR. However, 8 genes
selected using qRT-PCR are not selected using Affymetrix chips,
probably due to the better precision of qRT-PCR technology to
measure low RNA concentration with respect to Affymetrix chips.
doi:10.1371/journal.pone.0014390.g004
Figure 5. Average profile of the qRT-PCR selected genes. The 28
time series selected with qRT-PCR experiment are represented by the
average profile, characterized by an early rise of expression level at time
30 min, followed by an increasing down-regulation.
doi:10.1371/journal.pone.0014390.g005
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pharmacologic insulin concentration. It is thus impossible to make
any inference about the possible temporal effect in the presence of
physiological concentrations of the hormone.
We have also shown that in cluster 7 the 1-phoshatydilinositol-
3-kinase activity is negatively expressed. PI3K/Akt is involved in
both cytosolic and nuclear signaling in endothelial cell where it
regulates vascular homeostasis and angiogenesis [30,31]. PI3K
signaling mediates Akt/PKB phosphorylates eNOS at serine-1177
residue [32–34]. Insulin stimulates NO release by activating PI3/
Akt signaling [25]. Therefore, it is clear that insulin affects NO
production mainly through protein phosphorylation rather than
regulating protein gene expression [35]. It is therefore unclear why
we observed a negatively differentially expressed PI3K activity and
a divergent effect of gene expression of these two pathways, NOS
synthase activity and PI3K activity, apparently linked to each
other. This effect may be determined obviously by different
regulation of their gene expressions by insulin. Therefore, the
significance of these findings merits further consideration.
Our data show that insulin exposure significantly reduces the
average expression of genes in the electron transport chain
(Figure 5), with significant enrichment in GO group I: NADH
dehydrogenase activity (cluster 3, Figure 3). These findings
emphasize that electron transport chain is significantly regulated
by insulin and, probably, negatively regulated by the chronic
exposure to elevated concentrations of the hormone. Indeed, it has
been shown that insulin not only regulates this pathway [36] but
also that, in the presence of insulin resistance, electron transport
chain can be deeply altered [37,38].
In conclusion, the present data demonstrate that insulin affects
mRNA levels of about 1700 genes in HUVECs. These genes can
be clustered in groups with characteristic time expression profile
and classified into functional categories that can support the
biological effects of insulin. Microarray data were confirmed by
measuring the mRNA levels of a subset of genes using quantitative
real-time PCR. An important issue now is to understand how
insulin coordinates the expression of all these genes. The
identification of common elements in the promoter sequences of
group of genes will help the discovery of the transcription factors
linking the effect of insulin on multiple genes simultaneously. In
addition, since chronic hyperinsulinemia contributes to the
instability of the atherosclerotic plaque and stimulates cellular
proliferation, some of the genes identified in the present work are
potential novel candidates in diabetes complications related to
endothelial dysfunction. More focused studies on subsets of genes
and on several donors will be objective of future studies.
Supporting Information
Table S1. Selected genes. Table S1 contains an Excel file with
15 worksheets showing the selected genes belonging to each GO
group. In the file, for each group, the list of genes, their symbols,
titles, chromosome locations, expression clusters and FDR p-
values obtained by selection method are shown.
Found at: doi:10.1371/journal.pone.0014390.s001 (0.40 MB
XLS)
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